Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05629676 · ClinicalTrials.gov registry record · NA
Virtual Reality Intervention for Patients Undergoing BMT
A NA study of Bone Marrow Transplant Complications, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05629676 is a NA study of Bone Marrow Transplant Complications that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 313-participant average among 6 other Bone Marrow Transplant Complications trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05629676, a NA study of Bone Marrow Transplant Complications, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigned into one of the study groups: the virtual reality psychosocial intervention (BMT-VR) + usual care versus usual care alone. The BMT-VR intervention has several components: 1. Psychoeducation to enhance preparedness, manage expectations, and mobilize social supports. 2. Psychosocial skill building to promote effective coping and facilitate acceptance while living with uncertainty of treatment outcomes. 3. Self-care to promote effective coping and enhance patient's sense of control as they transition from inpatient to outpatient care
Conditions Studied
Interventions
- BEHAVIORAL BMT-VR
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Cancer Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-12-20 |
| Est. Completion | 2026-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05629676
The ClinicalTrials.gov registry entry for NCT05629676 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 313-participant average among 6 other Bone Marrow Transplant Complications trials with a reported enrollment target (74% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Marrow Transplant Complications appearing as the primary indexed condition, and to 1 intervention - of which BMT-VR is the first listed.
NCT05629676 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05629676 about?
NCT05629676 is a clinical study titled "Virtual Reality Intervention for Patients Undergoing BMT". The goal of this research study is to test the feasibility and preliminary efficacy of using a virtual reality (VR) psychosocial intervention for improving quality of life and psychological distress in patients hospitalized for bone marrow transplantation (BMT). Participants will be randomly assigne...
What is the current status of trial NCT05629676?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-12-20. Estimated completion is 2026-12-30.
What conditions does trial NCT05629676 study?
This clinical trial studies the following conditions: Bone Marrow Transplant Complications.
What interventions are being tested in trial NCT05629676?
The interventions under investigation include: BMT-VR (BEHAVIORAL).
Who is sponsoring clinical trial NCT05629676?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05629676 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Marrow Transplant Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
RECRUITING · NA
-
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
RECRUITING · NA
-
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
RECRUITING · NA
-
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
RECRUITING · NA
-
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
ACTIVE NOT RECRUITING · NA
-
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.